Niagen Bioscience, Inc. — Director's Dealing 2010

May 24, 2010

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC.OB)
CIK: 0001386570
Period of Report: 2010-05-24

Reporting Person: HALPRYN GLENN L (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	535714	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants to Purchase Common Stock	$0.21	2013-05-20	Common Stock (535714)		Indirect

Footnotes

F1: These Securities are held by IVC Investors, LLLP in which the Reporting Person has an interest. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose

F2: On May20, 2010, IVC Investors, LLLP purchases 535,714 shares of common stock and was issued an immediately exercisable warrant to acquire an additional 535,714 shares of common stock exercisable at $0.21 per share, See also Footnote 1